文献速递产科生殖医学母胎医学

自然周期与人工周期冻融胚胎移植围产结局的系统综述与荟萃分析

Lower risk of adverse perinatal outcomes in natural versus artificial frozen-thawed embryo transfer cycles: a systematic review and meta-analysis.
PubMed 文献 · Reprod Biomed Online · 2021-03-10

结果显示NC-FET与妊娠期高血压疾病、子痫前期、大于胎龄儿、巨大儿、早产、过期产、低出生体重、剖宫产、产后出血、胎盘早剥及胎盘植入风险显著降低相关。作者建议进一步开展随机对照试验,并强调对人工周期FET妊娠需加强产前、产时及产后监测。

要点

  • NC-FET较AC-FET显著降低妊娠期高血压疾病(RR 0.61)和子痫前期(RR 0.47)风险。
  • NC-FET较AC-FET显著降低大于胎龄儿(RR 0.93)和巨大儿(RR 0.82)风险。
  • NC-FET较AC-FET显著降低早产、低出生体重、剖宫产、产后出血、胎盘早剥及胎盘植入风险。

核心结论

  • 在IVF后单胎妊娠中,自然周期冻融胚胎移植较人工周期冻融胚胎移植显著降低多种不良围产结局风险。
  • 仍需随机对照试验进一步验证NC-FET与AC-FET对母婴结局的影响。

主要发现

  • NC-FET与AC-FET相比,妊娠期高血压疾病风险RR 0.61(95% CI 0.50–0.73),子痫前期风险RR 0.47(95% CI 0.42–0.53)。
  • 大于胎龄儿风险RR 0.93(95% CI 0.90–0.96),巨大儿风险RR 0.82(95% CI 0.69–0.97)。
  • 早产风险RR 0.83(95% CI 0.79–0.88),过期产风险RR 0.48(95% CI 0.29–0.80),低出生体重风险RR 0.84(95% CI 0.80–0.89)。
  • 剖宫产风险RR 0.84(95% CI 0.77–0.91),产后出血风险RR 0.39(95% CI 0.35–0.45),胎盘早剥风险RR 0.61(95% CI 0.38–0.98),胎盘植入风险RR 0.18(95% CI 0.10–0.33)。
  • 妊娠期高血压和小于胎龄儿风险在NC-FET与AC-FET间无显著差异。

关键数值与推荐

  • NC-FET较AC-FET显著降低妊娠期高血压疾病、子痫前期、大于胎龄儿、巨大儿、早产、过期产、低出生体重、剖宫产、产后出血、胎盘早剥及胎盘植入风险。
  • 妊娠期高血压和小于胎龄儿风险无显著差异。

临床怎么用

  • 临床医生应对通过人工周期冻融胚胎移植获得的妊娠在产前、产时及产后进行仔细监测。

局限性

  • 纳入研究均为观察性队列研究,需进一步随机对照试验验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

This systematic review of literature and meta-analysis of observational studies reports on perinatal outcomes after frozen embryo transfer (FET). The aim was to determine whether natural cycle frozen embryo transfer (NC-FET) in singleton pregnancies conceived after IVF decreased the risk of adverse perinatal outcomes compared with artificial cycle frozen embryo transfer (AC-FET). Thirteen cohort studies, including 93,201 cycles, met the inclusion criteria. NC-FET was associated with a lower risk of hypertensive disorders in pregnancy (HDP) (RR 0.61, 95% CI 0.50 to 0.73), preeclampsia (RR 0.47, 95% CI 0.42 to 0.53), large for gestational age (LGA) (RR 0.93, 95% CI 0.90 to 0.96) and macrosomia (RR 0.82, 95% CI 0.69 to 0.97) compared with AC-FET. No significant difference was found in the risk of gestational hypertension and small for gestational age. Secondary outcomes assessed were the risk of preterm birth (RR 0.83, 95% CI 0.79 to 0.88); post-term birth (RR 0.48, 95% CI 0.29 to 0.80); low birth weight (RR 0.84, 95% CI 0.80 to 0.89); caesarean section (RR 0.84, 95% CI 0.77 to 0.91); postpartum haemorrhage (RR 0.39, 95% CI 0.35 to 0.45); placental abruption (RR 0.61, 95% CI 0.38 to 0.98); and placenta accreta (RR 0.18, 95% CI 0.10 to 0.33). All were significantly lower with NC-FET compared with AC-FET. In assessing safety, NC-FET significantly decreased the risk of HDP, preeclampsia, LGA, macrosomia, preterm birth, post-term birth, low birth weight, caesarean section, postpartum haemorrhage, placental abruption and placenta accreta. Further randomized controlled trials addressing the effect of NC-FET and AC-FET on maternal and perinatal outcomes are warranted. Clinicians should carefully monitor pregnancies achieved by FET in artificial cycles prenatally, during labour and postnatally.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Moreno-Sepulveda J, Espinós JJ, Checa MA, et al. Lower risk of adverse perinatal outcomes in natural versus artificial frozen-thawed embryo transfer cycles: a systematic review and meta-analysis. Reprod Biomed Online. 2021. PMID: 33903031. doi:10.1016/j.rbmo.2021.03.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。